What Pharma.Aero does

Pharma.Aero is a Belgian non-profit (VZW) cross-industry collaboration platform dedicated to life sciences and MedTech logistics, founded in 2016 at the initiative of Brussels Airport and Miami International Airport. The organization connects approximately 93 member organizations—pharmaceutical manufacturers, airports, airlines, freight forwarders, ground handlers, packaging providers, and visibility-technology vendors—across six continents, convening them through working-group projects, a General Assembly, board governance, and member-led research programs. Member-facing projects span IoT devices and platforms, AI in pharma and MedTech supply chains, Cell & Gene Therapies, and Precision Therapy Logistics, with project leads drawn from member companies including MSD, Changi Airport Group, Brussels Airport, Miami International Airport, Dallas Fort Worth Airport, and Novartis.

The platform's product surface combines membership tiers (Strategic, Full, Associate, and the LMAP manufacturer advisory platform), structured training programs (the 4-day Pharma Logistics Masterclass across Frankfurt and Antwerp and the week-long Pharma Logistics Winter University), paid intelligence products (Pharmalytics quarterly reports), free-thought-leadership assets (white papers and the Pharma.Aero Insights podcast), and participation in flagship industry events (TIACA Executive Summit, Air Cargo China, FlyPharma Europe). Technology underpinnings are not a core proprietary offering; rather, the organization curates and disseminates member-supplied visibility, IoT sensor, and AI capabilities (e.g., ZoomLogi's AI-native control tower, Tec4med's IoT-enabled end-to-end visibility) and frames their integration through cross-industry projects rather than building the technology itself.

Pharma.Aero's revenue model is dominated by annual membership subscriptions paid in euros on a 30-day invoice cycle, supplemented by training program tuition (with member and student discounts), and exclusive content licensing (Pharmalytics, white papers). Membership pricing is voted on yearly at the General Assembly and is tiered by member category—Strategic seats for Life Science/MedTech manufacturers and airports carry voting rights and Board representation; Full memberships serve airports, airlines, and logistics stakeholders; Associate Partnerships serve product and service providers. Distribution is primarily direct (enterprise) membership sales supported by content marketing, LinkedIn, the podcast, and recurring industry event participation; the organization operates from a Machelen Cargo headquarters near Brussels Airport with a 1-10 person staff.

Name

Pharma.Aero

Legal name

Pharma.Aero VZW

Website

https://pharma.aero

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Pharma.Aero is a Belgian non-profit cross-industry collaboration platform serving Life Science and MedTech logistics, connecting 93 members—including pharmaceutical manufacturers, airports, airlines, and technology providers—across six continents through projects, research, training programs, and membership tiers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Logistics Collaboration

NAICS

Air Transportation (481)

SIC

Air Courier Services (4513), Airports, Flying Fields & Airport Terminal Services (4581)

akta.pro primary industry

Temperature-Controlled / Pharma Air Cargo Carriers (TLADAAAG)

akta.pro secondary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical logistics
• Life science supply chain
• Medtech cold chain
• Air cargo collaboration
• Pharma supply chain visibility

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Membership Fees: Pharma.Aero generates revenue through annual membership fees paid by Strategic Members, Full Members, and Associate Partners. Membership fees grant voting rights, participation rights in the General Assembly, access to projects, and ability to participate in events. Fees are reviewed and voted on yearly at the general meeting.
2. Training Programs: Revenue generated from the Pharma Logistics Masterclass program, including executive training programs that combine academic lectures, business presentations, workshops, and site visits. Employees of member companies receive significant registration discounts.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Pharma.Aero operates an international cross-industry collaboration platform that connects pharmaceutical manufacturers, airports, airlines, freight forwarders, ground-handlers, packaging companies, and technology providers to advance logistics for the Life Science and MedTech industries. It monetizes access to this ~93-member network via tiered memberships, while also delivering executive training programs (Pharma Logistics Masterclass and Winter University) and exclusive market intelligence products such as Pharmalytics quarterly reports, white papers, and the Pharma.Aero Insights podcast.

Product overview

Pharma.Aero is a cross-industry collaboration platform for Life Science and MedTech logistics. The organization offers a portfolio of services including professional training programs (Pharma Logistics Masterclass and Winter University), market intelligence products (Pharmalytics reports), industry publications (White Papers), and thought leadership content (Pharma.Aero Insights Podcast). The LMAP program enables manufacturer collaboration, while the core platform facilitates networking among 93 members including airports, airlines, freight forwarders, and technology providers across 6 continents. Key initiatives include projects focused on AI integration, IoT devices and platforms, Cell & Gene Therapies, and Precision Therapy Logistics.

Differentiator

Problem solved

Functional benefit

Brands

• Pharmalytics: Exclusive reports, white papers and data providing strategic market intelligence for pharmaceutical and MedTech logistics.
• Pharma Logistics Masterclass
• Pharma Logistics Winter University
• Pharma.Aero Insights Podcast
• LMAP

Products and services

• Cross-Industry Collaboration Membership Platform International membership-based collaboration platform connecting ~93 pharmaceutical manufacturers, airports, airlines, freight forwarders, ground-handlers, packaging companies, and technology providers to advance Life Science and MedTech logistics through joint projects, working groups, and the annual General Assembly.
• Pharma Logistics Masterclass A 4-day advanced executive training program for seasoned professionals, academics, and PhD students that combines lectures, business presentations, workshops, and site visits focused on pharmaceutical supply chain optimization. Employees of member companies receive significant registration discounts.
• Pharma Logistics Winter University A week-long intensive program of courses, workshops, and industry visits designed for management trainees and Master's students covering global supply chains, cold chain management, and industry innovations.
• Pharmalytics Exclusive quarterly strategic market intelligence reports providing focused analysis of developments shaping pharmaceutical and MedTech logistics, including geopolitics, trade rewiring, and supply chain resilience topics.
• Pharma.Aero Insights Podcast Podcast series featuring discussions with industry leaders, academics, and innovators on the complexity of life sciences and MedTech supply chain topics, including IoT, AI, and digitalization.
• White Papers Expert research publications and industry reports on topics such as Cell & Gene Therapies, Precision Therapy Logistics, and IoT in pharmaceutical logistics, distributed to members.

Quantifiable outcome

• Supply chain resilience during disruptions: Companies rerouting through alternative hubs (Jeddah, Riyadh, Oman, Istanbul, China, Singapore) when Middle East hubs disrupted
• +1 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

16 partnerships are on record, tiered core and minor.

• ZoomLogicoreTechnology or Integration · 29 June 2026ZoomLogi joined Pharma.Aero bringing advanced capabilities in AI-powered visibility, exception prediction, and automated intervention for healthcare and life sciences logistics. The platform unifies shipment data across couriers, ERP/TMS systems, and IoT sensors into a single live control tower, enabling real-time tracking and automated response playbooks.
• TAP Air CargocoreStrategic or Co-development Partner · 2 June 2026TAP Air Cargo, the cargo division of Portugal's flag carrier operating through Lisbon hub, has become a member of Pharma.Aero. The partnership strengthens collaboration across the pharmaceutical supply chain and reinforces connectivity between Europe, Americas, and Africa. TAP Air Cargo serves key pharmaceutical trade lanes with services designed to maintain product integrity and regulatory compliance.
• Air Cargo BelgiumcoreStrategic or Co-development Partner · 29 May 2026Air Cargo Belgium joined Pharma.Aero bringing extensive expertise in cargo community development, operational excellence, and stakeholder collaboration from one of Europe's leading pharmaceutical logistics hubs. The organization works to foster collaboration, sustainability, digital connectivity, and long-term industry development across the cargo value chain.
• Tec4medcoreTechnology or Integration · 4 May 2026Tec4med joined Pharma.Aero bringing advanced capabilities in end-to-end supply chain visibility for the life sciences sector. The company specializes in supply chain visibility combining next-generation IoT sensor technologies with a hardware-agnostic digital platform, enabling real-time monitoring across the full logistics journey. Backed by Cryoport Inc. for international reach and calibration services.
• Japan Airlines CargocoreStrategic or Co-development Partner · 16 April 2026Japan Airlines Cargo joined Pharma.Aero as the newest member, marking further integration of air cargo capabilities into pharmaceutical logistics. JAL Cargo operates a global network supporting international air freight including temperature-controlled transport for pharmaceutical and healthcare products, bringing operational insight into quality management, compliance, and end-to-end handling processes.
• Brussels AirportcoreStrategic or Co-development Partner · 1 January 2016Brussels Airport is a founding member of Pharma.Aero (founded 2016) and serves as Board liaison for multiple projects including the Precision Therapy Logistics project. As one of Europe's leading pharmaceutical logistics hubs, Brussels Airport provides strategic leadership and infrastructure support.
• Miami International AirportcoreStrategic or Co-development Partner · 1 January 2016Miami International Airport is a founding member of Pharma.Aero (founded 2016) and serves as project lead for the Cell & Gene Therapies project. The airport contributes operational expertise and serves as a key hub for pharmaceutical cargo in the Americas.
• University of AntwerpcoreStrategic or Co-development PartnerPharma.Aero collaborates with the University of Antwerp on the Pharma Logistics Masterclass program and research projects. The partnership combines academic insight with operational expertise, bringing together experts from industry and academia across the pharmaceutical and MedTech logistics ecosystem.
• Antwerp Management SchoolcoreStrategic or Co-development PartnerPharma.Aero collaborates with students from the Master's in Global Supply Chain Management at Antwerp Management School for research projects including the AI in Pharmaceutical & MedTech Supply Chains project. Their contribution brings additional analytical perspectives and strengthens the link between academic research and real-world industry challenges.
• Frankfurt University of Applied SciencesminorStrategic or Co-development PartnerPartner hosting Masterclass sessions as part of the 4-day executive training program taking place across Frankfurt and Antwerp in September 2026.
• Changi Airport GroupcoreStrategic or Co-development PartnerChangi Airport Group is represented on the Pharma.Aero Board of Directors (Vice Chair) and serves as Board liaison for the IoT Devices & Platforms project. The airport contributes strategic leadership for Southeast Asia connectivity and digital initiatives.
• Edmonton International AirportcoreStrategic or Co-development PartnerEdmonton International Airport is represented on the Pharma.Aero Board of Directors and served as Chair for two consecutive mandates (2022-2026). The airport contributes leadership and North American perspective to the organization.
• ZoetiscoreStrategic or Co-development PartnerZoetis, a global animal health company, holds the Chair position of Pharma.Aero for 2026-2028 through Director of Global Logistics Sourcing & Sustainability Gergely Szorcsik. This marks the first time since the organization's creation in 2016 that the Chair position is held by a pharmaceutical company.
• MSDcoreStrategic or Co-development PartnerMSD is represented on the Pharma.Aero Board of Directors and serves as project lead for the AI in Pharmaceutical & MedTech Supply Chains project, contributing pharmaceutical manufacturer perspective to AI integration research.
• Dallas Fort Worth AirportcoreStrategic or Co-development PartnerDallas Fort Worth Airport serves as project lead for the Cell & Gene Therapies project alongside Brussels Airport and Novartis, contributing expertise in advanced therapy logistics.
• NovartiscoreStrategic or Co-development PartnerNovartis serves as project co-lead for the Precision Therapy Logistics project alongside Brussels Airport and Dallas Fort Worth Airport, providing pharmaceutical manufacturer perspective on radioligand therapies and advanced medicinal products.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• World Courier (Cencora): Large specialty logistics provider for pharma and MedTech, owned by Cencora; operates in the same pharma logistics value chain that Pharma.Aero's members serve and participates as a stakeholder in pharma logistics standards.
• International Air Transport Association (IATA): Global airline trade body that sets standards and runs Time and Temperature Task Forces for pharma air cargo; a much larger incumbent whose pharma initiatives compete for attention from the same airline and shipper members.
• Airports Council International (ACI) World: Global airport industry association representing many of the same airport members as Pharma.Aero (Brussels, Miami, Changi, DFW); competes for airport membership dues and pharma-cargo thought leadership.
• DHL Life Sciences & Healthcare: Global integrator with a dedicated Life Sciences & Healthcare vertical operating temperature-controlled air freight; comparable end-market focus and frequently engages with Pharma.Aero's pharma manufacturing members.

Direct peers

• Cool Chain Association (CCA): Pharmaceutical-focused air cargo association that directly overlaps with Pharma.Aero's temperature-controlled pharma logistics agenda, serving many of the same airports, airlines, and forwarders.
• The International Air Cargo and Tanker Association (TIACA): Global air cargo industry association that Pharma.Aero actively partners with on events like the TIACA Executive Summit and Air Cargo Forum; both convene cargo stakeholders and compete for the same corporate members and sponsorship dollars.

Others

• The International Association for the Pharmaceutical and Medical Device Industry (MedTech Europe): European MedTech industry association whose members overlap with Pharma.Aero's Life Science & MedTech manufacturer segment on logistics and supply chain policy matters.
• European Shippers' Council (ESC): European shipper interest group covering freight including pharma flows; an adjacent industry stakeholder that engages with the same pharma shippers Pharma.Aero represents.

Regional players

• Cold Chain Federation: UK-focused cold chain industry body addressing temperature-controlled logistics for food and pharma; comparable in mission to Pharma.Aero but concentrated in the UK market rather than globally.

Emerging players

• BioPharma Logistics Coalition: Emerging industry coalition focused on biopharma cold chain standards; competes with Pharma.Aero for thought-leadership in the biopharma logistics niche and targets overlapping manufacturer and logistics audiences.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pharma.aero

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma.Aero